Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans
SO Sow, BJ Okoko, A Diallo, S Viviani… - … England Journal of …, 2011 - Mass Medical Soc
Background Group A meningococci are the source of major epidemics of meningitis in
Africa. An affordable, highly immunogenic meningococcal A conjugate vaccine is needed …
Africa. An affordable, highly immunogenic meningococcal A conjugate vaccine is needed …
Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans
SO Sow, BJ Okoko, A Diallo, S Viviani, R Borrow… - 2011 - documentation.ird.fr
Background Group A meningococci are the source of major epidemics of meningitis in
Africa. An affordable, highly immunogenic meningococcal A conjugate vaccine is needed …
Africa. An affordable, highly immunogenic meningococcal A conjugate vaccine is needed …
Immunogenicity and safety of a meningococcal a conjugate vaccine in Africans
SO Sow, BJ Okoko, A Diallo… - New England …, 2011 - researchportal.ukhsa.gov.uk
Background: Group A meningococci are the source of major epidemics of meningitis in
Africa. An affordable, highly immunogenic meningococcal A conjugate vaccine is needed …
Africa. An affordable, highly immunogenic meningococcal A conjugate vaccine is needed …
Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans.
SO Sow, BJ Okoko, A Diallo, S Viviani, R Borrow… - 2011 - cabidigitallibrary.org
BACKGROUND: Group A meningococci are the source of major epidemics of meningitis in
Africa. An affordable, highly immunogenic meningococcal A conjugate vaccine is needed …
Africa. An affordable, highly immunogenic meningococcal A conjugate vaccine is needed …
[PDF][PDF] Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans
SO Sow, BJ Okoko, A Diallo, S Viviani, R Borrow… - N Engl J Med, 2011 - academia.edu
Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans Page 1 The
new england journal of medicine n engl j med 364;24 nejm.org june 16, 2011 2293 original …
new england journal of medicine n engl j med 364;24 nejm.org june 16, 2011 2293 original …
[引用][C] Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans
SO SOW, BJ OKOKO, C ELIE… - The New England …, 2011 - pascal-francis.inist.fr
Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
[PDF][PDF] Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans
SO Sow, BJ Okoko, A Diallo, S Viviani, R Borrow… - N Engl J …, 2011 - researchgate.net
Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans Page 1 The
new england journal of medicine n engl j med 364;24 nejm.org june 16, 2011 2293 original …
new england journal of medicine n engl j med 364;24 nejm.org june 16, 2011 2293 original …
Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans.
SO Sow, BJ Okoko, A Diallo, S Viviani… - The New England …, 2011 - europepmc.org
Background Group A meningococci are the source of major epidemics of meningitis in
Africa. An affordable, highly immunogenic meningococcal A conjugate vaccine is needed …
Africa. An affordable, highly immunogenic meningococcal A conjugate vaccine is needed …
Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans
SO Sow, BJ Okoko, A Diallo, S Viviani, R Borrow… - 2011 - pubmed.ncbi.nlm.nih.gov
Background Group A meningococci are the source of major epidemics of meningitis in
Africa. An affordable, highly immunogenic meningococcal A conjugate vaccine is needed …
Africa. An affordable, highly immunogenic meningococcal A conjugate vaccine is needed …
Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans
SO Sow, BJ Okoko, A Diallo, S Viviani, R Borrow… - 2011 - documentation.ird.fr
Background Group A meningococci are the source of major epidemics of meningitis in
Africa. An affordable, highly immunogenic meningococcal A conjugate vaccine is needed …
Africa. An affordable, highly immunogenic meningococcal A conjugate vaccine is needed …